|
Subscribe / Renew |
|
|
Contact Us |
|
| ► Subscribe to our Free Weekly Newsletter | |
| home | Welcome, sign in or click here to subscribe. | login |
| |
November 9, 2023
Parse Biosciences, a provider of accessible and scalable single cell sequencing solutions, announced an agreement with India-based Spinco Biotech to further extend its reach in Asia. This is Parse's latest expansion in the region following an agreement last year with Research Instruments Pte Ltd to distribute its products in Southeast Asia. The company's agreement with Spinco Biotech will give researchers in India full access to its single cell portfolio. The agreement is a continuation of Parse's ongoing introduction of its products in international markets, which are also currently available in North America, Europe, Australia, South Korea, Singapore, Israel, and New Zealand. Spinco is a solution provider and distribution company, specializing in analytical and life science instrumentation. With technology developed at The University of Washington by co-founders Alex Rosenberg and Charles Roco, Parse has raised over $50 million in capital and is now used by over 1,000 customers across the world. Its headquarters and laboratory are based in Seattle's South Lake Union district.